Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
RIGL: Rigel Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
RIGL
The Story
RIGL
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Operating margin
41.6%
ROIC
28.0%
Financially safe
Strong
Debt / equity
0.11×
Interest coverage
18.1×
Current ratio
2.62×
Valuation
Unrated
P/E ratio
1.8×
Rigel Pharmaceuticals, Inc.
RIGL
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Rigel Pharmaceuticals, Inc.
RIGL
NASDAQ
·
USD
·
Closed
$36.81
−3.28%
$36.81
−$1.25 (3.28%)
52W Range
49th
pctl
Volume
0.44×
avg
Mkt Cap
681.06M
USD
P/E
1.8
TTM
Div Yield
–
ann
52W Range
49th
pctl
Volume
0.44×
avg
Market Cap
681.06M
USD
P/E Ratio
1.8
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings